DK1685131T3 - Hydroxyalkylsubstituerede pyrido-7-pyrimidin-7-oner - Google Patents

Hydroxyalkylsubstituerede pyrido-7-pyrimidin-7-oner

Info

Publication number
DK1685131T3
DK1685131T3 DK04797601T DK04797601T DK1685131T3 DK 1685131 T3 DK1685131 T3 DK 1685131T3 DK 04797601 T DK04797601 T DK 04797601T DK 04797601 T DK04797601 T DK 04797601T DK 1685131 T3 DK1685131 T3 DK 1685131T3
Authority
DK
Denmark
Prior art keywords
pyrimidin
hydroxyalkyl
ones
substituted pyrido
pyrido
Prior art date
Application number
DK04797601T
Other languages
Danish (da)
English (en)
Inventor
David Michael Goldstein
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1685131T3 publication Critical patent/DK1685131T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK04797601T 2003-11-13 2004-11-04 Hydroxyalkylsubstituerede pyrido-7-pyrimidin-7-oner DK1685131T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51978903P 2003-11-13 2003-11-13
PCT/EP2004/012475 WO2005047284A1 (en) 2003-11-13 2004-11-04 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones

Publications (1)

Publication Number Publication Date
DK1685131T3 true DK1685131T3 (da) 2007-07-09

Family

ID=34590444

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04797601T DK1685131T3 (da) 2003-11-13 2004-11-04 Hydroxyalkylsubstituerede pyrido-7-pyrimidin-7-oner

Country Status (26)

Country Link
US (2) US7348331B2 (pt)
EP (1) EP1685131B1 (pt)
JP (1) JP4616839B2 (pt)
KR (1) KR100816321B1 (pt)
CN (1) CN100455582C (pt)
AR (1) AR046705A1 (pt)
AT (1) ATE356124T1 (pt)
AU (1) AU2004289428B2 (pt)
BR (1) BRPI0416030A (pt)
CA (1) CA2544247A1 (pt)
CO (1) CO5690600A2 (pt)
DE (1) DE602004005238T2 (pt)
DK (1) DK1685131T3 (pt)
ES (1) ES2281843T3 (pt)
HR (1) HRP20070132T3 (pt)
IL (1) IL175284A0 (pt)
MY (1) MY141011A (pt)
NO (1) NO20062256L (pt)
NZ (1) NZ546634A (pt)
PL (1) PL1685131T3 (pt)
PT (1) PT1685131E (pt)
RU (1) RU2348632C2 (pt)
SI (1) SI1685131T1 (pt)
TW (1) TWI349670B (pt)
WO (1) WO2005047284A1 (pt)
ZA (1) ZA200603829B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008011032A1 (en) 2006-07-17 2008-01-24 Amgen Inc. Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors
CN101568518A (zh) * 2006-12-22 2009-10-28 霍夫曼-拉罗奇有限公司 用于氨基亚烷基二醇合成的化合物和方法
WO2008151992A2 (en) * 2007-06-15 2008-12-18 F. Hoffmann-La Roche Ag A novel process for the preparation of 3-amino-pentan-1,5-diol
JP5797664B2 (ja) * 2009-12-18 2015-10-21 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイションＴｅｍｐｌｅ Ｕｎｉｖｅｒｓｉｔｙ−Ｏｆ Ｔｈｅ Ｃｏｍｍｏｎｗｅａｌｔｈ Ｓｙｓｔｅｍ Ｏｆ Ｈｉｇｈｅｒ Ｅｄｕｃａｔｉｏｎ 置換ピリド［２，３−ｄ］ピリミジン−７（８Ｈ）−オン及びそれらの治療用の使用
PT3102577T (pt) * 2014-02-07 2018-10-23 Principia Biopharma Inc Derivados de quinolona como inibidores do recetor do fator de crescimento de fibroblastos
AU2016304852B2 (en) 2015-08-11 2020-12-10 Principia Biopharma, Inc. Processes for preparing an FGFR inhibitor
CN105418609B (zh) * 2015-12-31 2017-06-23 山东大学 4‑(1,2,3‑三氮唑取代苯胺基)‑吡啶骈嘧啶酮衍生物及其制备方法与应用
US20190060286A1 (en) 2016-02-29 2019-02-28 University Of Florida Research Foundation, Incorpo Chemotherapeutic Methods
US20180126000A1 (en) 2016-06-02 2018-05-10 Abbvie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof
ES2866883T3 (es) 2016-06-08 2021-10-20 Support Venture Gmbh Combinaciones farmacéuticas para el tratamiento del cáncer
BR112019003006A2 (pt) 2016-08-17 2019-05-14 Support-Venture Gmbh uso de uma combinação farmacêutica e kit para prevenir ou tratar perda auditiva
BR112019020754A2 (pt) * 2017-04-04 2020-04-28 Strekin Ag métodos de prevenção ou tratamento de doenças oftalmológicas
BR112020006677A2 (pt) 2017-10-05 2020-10-06 Fulcrum Therapeutics, Inc. uso de inibidores p38 para reduzir a expressão de dux4
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
BR112020010694A2 (pt) 2017-12-01 2020-11-10 Abbvie Inc. agonista de receptor de glicocorticoides e imunoconjugados do mesmo
ES2929406T3 (es) 2018-05-21 2022-11-29 Nerviano Medical Sciences Srl Compuestos de piridonas heterocondensadas y su uso como inhibidores de IDH
KR20210031909A (ko) 2018-07-13 2021-03-23 키나루스 아게 섬유증 질환을 예방 또는 치료하기 위한 ppar 효능제 및 p38 키나제 억제제의 조합물
CN115038700B (zh) 2019-11-08 2025-07-25 内尔维亚诺医疗科学公司 偕二取代的杂环化合物及其作为idh抑制剂的用途
US20230263803A1 (en) 2020-08-11 2023-08-24 Kinarus Ag Methods of preventing or treating covid-19 and related viral diseases or disorders

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215216A (en) 1979-04-18 1980-07-29 American Home Products Corporation 7,8-Dihydro-2,5,8-trisubstituted-7-oxo-pyrido[2,3-d]pyrimidine-6-carboxylic acid derivatives
US5037826A (en) 1986-10-15 1991-08-06 Schering Corporation 1-substituted naphthyridine and pyridopyrazine derivatives
EP0278686A1 (en) 1987-02-07 1988-08-17 The Wellcome Foundation Limited Pyridopyrimidines methods for their preparation and pharmaceutical formulations thereof
US5149699A (en) * 1991-10-24 1992-09-22 American Home Products Corporation Substituted pyridopyrimidines useful as antgiotensin II antagonists
WO1993017682A1 (en) 1992-03-04 1993-09-16 Abbott Laboratories Angiotensin ii receptor antagonists
IL115256A0 (en) 1994-11-14 1995-12-31 Warner Lambert Co 6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
PL181893B1 (pl) 1994-11-14 2001-10-31 Warner Lambert Co Zwiazki bedace pochodnymi pirymidyny i naftyrydyny oraz preparat farmaceutyczny zawierajacy je PL PL PL
US5620981A (en) 1995-05-03 1997-04-15 Warner-Lambert Company Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
IL117923A (en) 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
WO1998033798A2 (en) 1997-02-05 1998-08-06 Warner Lambert Company Pyrido[2,3-d]pyrimidines and 4-amino-pyrimidines as inhibitors of cell proliferation
US5945422A (en) 1997-02-05 1999-08-31 Warner-Lambert Company N-oxides of amino containing pyrido 2,3-D! pyrimidines
TR200003429T2 (tr) 1998-05-26 2001-07-23 Warner-Lambert Company Hücresel çoğalma inhibitörleri olarak bisiklik pirimidinler ve bisiklik 3,4-dihidropirimidinler.
US7053070B2 (en) 2000-01-25 2006-05-30 Warner-Lambert Company Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors
JP2003523358A (ja) 2000-01-27 2003-08-05 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 神経変性疾患の治療のためのピリドピリミジノン誘導体
AP2002002643A0 (en) 2000-03-06 2002-12-31 Warner Lambert Co 5-alkylpyrido[2,3-d]pyrimidines tyrosine kinase inhibitors
US6518276B2 (en) 2000-08-31 2003-02-11 Syntex (U.S.A.) Llc 7-oxo-pyridopyrimidines (II)
CA2420286A1 (en) * 2000-08-31 2002-03-07 F. Hoffmann-La Roche Ag 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation
DE60206363T2 (de) * 2001-02-12 2006-07-06 F. Hoffmann-La Roche Ag 6-substituierte pyridopyrimidine
MXPA04005939A (es) 2002-01-22 2005-01-25 Warner Lambert Co 2-(piridin-2-ilamino)-pirido[2,3-d]pirimidin-7-onas.
FR2897336B1 (fr) 2006-02-10 2010-07-30 Ranger France Support d'aile pour vehicule automobile

Also Published As

Publication number Publication date
RU2006120486A (ru) 2008-01-20
CN100455582C (zh) 2009-01-28
US20080119497A1 (en) 2008-05-22
AU2004289428B2 (en) 2010-06-03
RU2348632C2 (ru) 2009-03-10
DE602004005238D1 (de) 2007-04-19
EP1685131A1 (en) 2006-08-02
US20050107408A1 (en) 2005-05-19
TW200526657A (en) 2005-08-16
EP1685131B1 (en) 2007-03-07
KR20060086417A (ko) 2006-07-31
US7348331B2 (en) 2008-03-25
CA2544247A1 (en) 2005-05-26
PL1685131T3 (pl) 2007-08-31
HRP20070132T3 (en) 2007-05-31
ES2281843T3 (es) 2007-10-01
KR100816321B1 (ko) 2008-03-24
CO5690600A2 (es) 2006-10-31
JP2007510686A (ja) 2007-04-26
BRPI0416030A (pt) 2007-01-02
ATE356124T1 (de) 2007-03-15
AU2004289428A1 (en) 2005-05-26
HK1099021A1 (zh) 2007-08-03
CN1882585A (zh) 2006-12-20
JP4616839B2 (ja) 2011-01-19
US7750016B2 (en) 2010-07-06
MY141011A (en) 2010-02-25
AR046705A1 (es) 2005-12-21
IL175284A0 (en) 2006-09-05
NO20062256L (no) 2006-06-06
SI1685131T1 (sl) 2007-06-30
TWI349670B (en) 2011-10-01
NZ546634A (en) 2010-01-29
WO2005047284A1 (en) 2005-05-26
PT1685131E (pt) 2007-05-31
DE602004005238T2 (de) 2007-11-08
ZA200603829B (en) 2007-10-31

Similar Documents

Publication Publication Date Title
ATE363383T1 (de) Schlingenware
DE502004001683D1 (de) Kabelführung
AT502792A5 (de) Düsenanpressvorrichtung
DK1685131T3 (da) Hydroxyalkylsubstituerede pyrido-7-pyrimidin-7-oner
DE112004000620D2 (de) Struktoguss
DE502004000672D1 (de) Pigmentpreparationen
DE502004008321D1 (de) Bandaufwickelverfahren
DE10355350A8 (de) Elektromodul
DE502004001524D1 (de) Hydrolager
ATA662003A (de) Trink-mundstück
ATE446959T1 (de) Chromenonindole
DE502004002978D1 (de) N-biarylamide
DE502004009786D1 (de) Rdnung
DE502004001629D1 (de) Bremsenprüfstand
DE502004003122D1 (de) Hydrolager
DE112004002227D2 (de) Nietverarbeitungsgerät
DE502004000518D1 (de) Mitgängergabelhubwagen
DE502004005162D1 (de) Leistungsregelvorricthung
DE502004006563D1 (de) Brieftaubenkonstatiersystem
DE10394329D2 (de) Mäanderstent
DE10329218B4 (de) Hotflue
ATE406350T1 (de) Prolinylarylacetamide
DE502004007251D1 (de) En 2-arylpropenalen
DE502004002771D1 (de) Umlenkhebel
DE502004004175D1 (de) Verbrennungskraftmaschime